Effectiveness of bipolar disorder treatment may depend on patient’s genes

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

A group of international scientists investigated how a patient’s genetic make-up could impact the effects of the drug lithium, which is used to treat mood disorders including bipolar and depression.

Despite being the most effective bipolar treatment available, the study found that lithium only works for about a third of the people who take it.

University of New South Wales’ head of psychiatry Philip Mitchell, one of the co-authors of the study, said they had found that while one third of patients did partially well, one third did not respond at all.

ADVERTISEMENT

“Bipolar disorder is a very difficult condition to treat,” he said.

“It’s very disruptive and also over time, it’s recurrent, so people have repeated episodes of manic highs and depressed lows which really damage people’s lives.

“The imperative is to stop those episodes recurring. When you get the treatment correct though, it can just make an enormous difference to people’s lives.”

The study, published in the Lancet journal, was a collaboration between researchers all over the world from the International Consortium on Lithium Genetics.

ADVERTISEMENT
ADVERTISEMENT

The researchers concluded that different genetic markers may determine how well patients respond to the lithium.

“There’s been growing evidence that the response to lithium appears to run in families, which has suggested that there are probably genetic determinants of who benefits from lithium,” Professor Mitchell said.

Read full, original post: Bipolar treatment: Genetics change people’s response to lithium, study finds

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
seralinistud

Gilles-Éric Séralini: Activist professor and face of anti-GMO industry

The French biologist and his research team--funded by the Rodale ...
vandana shiva

Vandana Shiva: ‘Rock Star’ of GMO protest movement has anti-science history

In a 2012 interview, Bill Moyers referred to Vandana Shiva as ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend